By Counterforce Health Team in Opsumit (macitentan) —

Complete Guide: Getting Opsumit (Macitentan) Covered by UnitedHealthcare in Washington - Forms, Appeals & Timeline

Answer Box: Getting Opsumit Covered by UnitedHealthcare in Washington

Opsumit (macitentan) requires prior authorization through OptumRx for all UnitedHealthcare plans in Washington. You'll need PAH diagnosis confirmed by right heart catheterization, WHO Functional Class II-IV documentation, and specialist prescriber. Submit via the UnitedHealthcare Provider Portal or fax to 1-844-403-1027. If denied, Washington's external review through an Independent Review Organization (IRO) provides binding decisions within 30 days. Start by gathering your right heart cath results, functional class assessment, and prior therapy records today.

Table of Contents

  1. Who Should Use This Guide
  2. Member & Plan Basics
  3. Clinical Criteria for Opsumit
  4. Documentation Requirements
  5. Submission Process
  6. Specialty Pharmacy Requirements
  7. After Submission: Tracking Your Request
  8. Common Denial Reasons & How to Fix Them
  9. Appeals Process in Washington
  10. Cost Savings & Patient Support
  11. Printable Checklist

Who Should Use This Guide

This comprehensive guide helps patients and clinicians navigate UnitedHealthcare's prior authorization process for Opsumit (macitentan) in Washington state. You'll find this useful if you're dealing with:

  • Initial prior authorization requests for newly diagnosed PAH patients
  • Reauthorization for existing Opsumit therapy (though UnitedHealthcare eliminated many reauths effective May 2025)
  • Appeal strategies after a denial
  • External review through Washington's IRO process

Expected outcome: With proper documentation, most PAH cases meeting clinical criteria get approved within 30-45 days. Washington's strong external review process gives you excellent appeal options if initially denied.

Member & Plan Basics

Coverage Requirements

All UnitedHealthcare plans require prior authorization for Opsumit, managed through OptumRx. This includes:

  • Commercial plans
  • Medicare Part D
  • Medicare Advantage
  • Golden Rule plans (effective January 1, 2025)

Plan Verification Steps

Before starting your prior authorization:

  1. Confirm active coverage via your member ID card
  2. Check formulary status using the PreCheck MyScript Tool - Opsumit typically appears as Tier 4-5
  3. Verify deductible status - specialty drugs often apply to medical or pharmacy deductibles
  4. Identify your specialty pharmacy network through OptumRx
Tip: UnitedHealthcare's PreCheck tool now auto-approves 62% of eligible prior authorizations in a median of 29 seconds for qualifying drugs.

Clinical Criteria for Opsumit

FDA-Approved Indication

Opsumit is approved for pulmonary arterial hypertension (PAH, WHO Group 1) to delay disease progression and reduce hospitalization risk.

UnitedHealthcare's Medical Necessity Requirements

Requirement Details Documentation Needed
PAH Diagnosis WHO Group 1 confirmed by right heart catheterization RHC report showing mean PAP ≥25 mmHg, PCWP ≤15 mmHg
Functional Class WHO/NYHA Class II, III, or IV 6-minute walk test, symptom assessment
Specialist Prescriber Cardiologist or pulmonologist Provider credentials verification
Prior Therapy Trial/failure of preferred agents unless contraindicated Medication history, intolerance documentation

Key ICD-10 Codes

  • I27.0 - Primary pulmonary hypertension (most common)
  • I27.21 - Pulmonary arterial hypertension, idiopathic
  • I27.29 - Other pulmonary arterial hypertension

Documentation Requirements

Essential Clinical Documentation

Your prior authorization packet must include:

1. Right Heart Catheterization Results

  • Mean pulmonary artery pressure ≥25 mmHg
  • Pulmonary capillary wedge pressure ≤15 mmHg
  • Pulmonary vascular resistance >3 Wood units
  • Exclusion of left heart disease

2. Functional Class Assessment

Document specific WHO/NYHA class with supporting evidence:

  • Class II: Slight limitation; dyspnea with ordinary activity
  • Class III: Marked limitation; comfortable at rest, symptoms with minimal activity
  • Class IV: Symptoms at rest

Include 6-minute walk distance if available.

3. Prior Therapy Documentation

UnitedHealthcare typically requires trials of:

  • PDE-5 inhibitors (sildenafil, tadalafil)
  • Endothelin receptor antagonists (bosentan, ambrisentan)

Document specific medications tried, doses, duration, and reasons for discontinuation.

Medical Necessity Letter Components

Your prescriber's letter should address:

  1. Patient demographics and diagnosis with ICD-10 code
  2. Right heart catheterization findings confirming PAH
  3. Current functional status and symptoms
  4. Prior treatments attempted and outcomes
  5. Clinical rationale for Opsumit specifically
  6. Treatment goals and monitoring plan
Important: The FDA discontinued Opsumit's REMS pregnancy testing program, but the black box warning for embryo-fetal toxicity remains. Pregnancy testing is still recommended before starting therapy in women of reproductive potential.

Submission Process

Step-by-Step Submission

1. Choose Your Submission Method

2. Use the Correct Form Download the current PAH Oral/Inhalation Prior Authorization Form for Washington.

3. Complete Required Fields

  • Member information and plan details
  • Prescriber information and NPI
  • Medication details (strength, quantity, directions)
  • ICD-10 diagnosis code
  • Clinical justification

4. Attach Supporting Documents

  • Right heart catheterization report
  • Echocardiogram results
  • 6-minute walk test results
  • Prior medication trial documentation
  • Lab results (liver function, hemoglobin)

Timeline Expectations

  • Standard review: 30-45 days
  • Expedited review: 72 hours (for urgent cases)
  • Auto-approval eligible: Some cases resolve in under 30 seconds via PreCheck

Specialty Pharmacy Requirements

UnitedHealthcare's Specialty Network

Opsumit must be dispensed through UnitedHealthcare's specialty pharmacy network, which includes:

  • OptumRx Specialty Pharmacy
  • Optum Frontier Therapies
  • Optum Infusion Pharmacy
  • Genoa Healthcare

Transfer Process

Once your prior authorization is approved:

  1. Prescription routing: Your doctor sends the prescription to the designated specialty pharmacy
  2. Patient enrollment: The pharmacy contacts you to set up delivery
  3. Clinical support: Specialty pharmacists provide ongoing monitoring and support
  4. Delivery coordination: Monthly shipments directly to your home
Note: Verify with the specialty pharmacy that they can confirm your prior authorization approval before processing your first shipment.

After Submission: Tracking Your Request

Confirmation Steps

Immediately after submission:

  • Record your confirmation number
  • Save submission receipt/timestamp
  • Note the review timeline provided

Status Checking

Monitor your request via:

  • UnitedHealthcare Provider Portal status updates
  • Phone: 866-889-8054 (have member ID ready)
  • Specialty pharmacy coordination calls

Documentation to Maintain

Keep records of:

  • All submission confirmations
  • Phone call logs with representatives
  • Any additional information requests
  • Timeline updates or delays

Common Denial Reasons & How to Fix Them

Denial Reason How to Overturn Required Documentation
Missing RHC documentation Submit complete catheterization report Full hemodynamic measurements, exclusion of other PH types
Inadequate functional class Provide detailed symptom assessment 6MWT results, NYHA/WHO class justification
Insufficient prior therapy Document specific trials and failures Medication names, doses, duration, discontinuation reasons
Non-specialist prescriber Transfer to pulmonologist/cardiologist New prescription from qualified specialist
Incomplete pregnancy testing Submit negative test results Current pregnancy test for women of reproductive age

Counterforce Health's Appeal Support

When facing complex denials, Counterforce Health specializes in turning insurance denials into targeted, evidence-backed appeals. Their platform analyzes your denial letter and plan policy to create point-by-point rebuttals aligned with your insurer's own rules, incorporating the right clinical evidence and procedural requirements for your specific case.

Appeals Process in Washington

Internal Appeals (First Step)

Timeline: 180 days from denial date to file Process:

  1. Submit written appeal to UnitedHealthcare
  2. Include additional clinical evidence
  3. Request peer-to-peer review if available
  4. Expect decision within 30 days (72 hours for urgent)

External Review Through IRO

Washington provides robust external review rights through Independent Review Organizations (IROs).

Key Features:

  • Timeline: 180 days from final internal denial to request external review
  • Process: Submit request to Washington Office of Insurance Commissioner or directly to UnitedHealthcare
  • Decision timeline: 30 days for standard review, 72 hours for expedited
  • Binding: IRO decisions are legally binding on UnitedHealthcare

Washington Insurance Commissioner Support

Contact Information:

  • Phone: 1-800-562-6900 (Consumer Advocacy line)
  • Website: Washington State Office of Insurance Commissioner
  • Services: Appeal guidance, template letters, complaint filing

What they provide:

  • Step-by-step appeal guidance
  • Template appeal letters
  • Direct assistance with complex cases
  • Oversight of IRO performance
Washington Advantage: The state's proactive Insurance Commissioner and strong external review law make Washington one of the most consumer-friendly states for overturning insurance denials.

Cost Savings & Patient Support

Manufacturer Support Programs

Opsumit Copay Program

  • Eligible commercially insured patients may pay as little as $10 per month
  • Income and insurance restrictions apply
  • Apply at Opsumit.com

Foundation Grants

Patient Access Network (PAN) Foundation

  • Provides grants for PAH medications
  • Income-based eligibility
  • Apply online with diagnosis verification

Washington State Programs

Apple Health (Medicaid)

  • Expanded Medicaid covers specialty drugs
  • Separate fair hearing process for denials
  • Contact Washington Health Benefit Exchange for eligibility

Printable Checklist

Before You Start

  • Insurance card and member ID
  • Right heart catheterization report
  • Echocardiogram results
  • 6-minute walk test results
  • Prior medication trial records
  • Current lab results (liver function, CBC)
  • Prescriber contact information

Documentation Packet

  • Completed PA form with all required fields
  • Medical necessity letter from specialist
  • Right heart cath report showing PAH confirmation
  • Functional class assessment (WHO/NYHA II-IV)
  • Prior therapy documentation
  • ICD-10 code I27.0 or I27.21/I27.29

Submission

  • Submit via UnitedHealthcare Provider Portal or fax 1-844-403-1027
  • Save confirmation number
  • Set calendar reminder for status check in 2 weeks
  • Contact specialty pharmacy to coordinate filling

If Denied

  • Review denial letter for specific reasons
  • Gather additional documentation to address gaps
  • File internal appeal within 180 days
  • Consider Counterforce Health for complex appeals
  • Prepare for external IRO review if needed

Frequently Asked Questions

Q: How long does UnitedHealthcare prior authorization take for Opsumit in Washington? A: Standard review takes 30-45 days. Urgent cases qualify for 72-hour expedited review. Some cases auto-approve in under 30 seconds via PreCheck.

Q: What if Opsumit isn't on my formulary? A: Most UnitedHealthcare plans cover Opsumit as a Tier 4-5 specialty drug requiring prior authorization. Non-formulary cases need medical exception requests with strong clinical justification.

Q: Can I request expedited review? A: Yes, if your condition could seriously deteriorate without immediate treatment. Your doctor must document medical urgency for 72-hour review.

Q: Does Washington's external review cost anything? A: No, external IRO review is free to patients. UnitedHealthcare pays the IRO fees as required by Washington law.

Q: What happens if I move from another state while on Opsumit? A: UnitedHealthcare typically honors existing authorizations during plan transitions. Contact member services to confirm continuation and specialty pharmacy transfer.

Sources & Further Reading

Disclaimer: This guide provides general information about insurance coverage processes and should not be considered medical advice. Coverage decisions depend on individual plan terms and clinical circumstances. Always consult with your healthcare provider and insurance plan for specific guidance. For additional help with appeals in Washington, contact the Office of the Insurance Commissioner at 1-800-562-6900.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.